Bismuth-based first-line therapy for Helicobacter pylori eradication in type 2 diabetes mellitus patients.

Abstract

BACKGROUND/AIM The primary aim of this study was to assess the efficacy of a bismuth-based quadruple regimen as first-line therapy for Helicobacter pylori (HP) eradication in diabetes mellitus (DM) patients. The secondary aim was to study the effect of HP eradication on dyspeptic symptoms in DM patients. METHOD Eighty-nine consecutive type 2 DM and 48 non… (More)
DOI: 10.1159/000236024

Topics

  • Presentations referencing similar topics